ChemicalBook
English   Japanese   Germany   Korea

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione

, 40785-65-7, 结构式
CAS号:
40785-65-7
英文名:
(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
英文别名:
F-5-4;8'-epi-Hydroxyzearalenone;(-)-8'-epi-Hydroxyzearalenone;(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione;1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-5,14,16-trihydroxy-3-methyl-, (3S,5S,11E)-;[3S,5S,11E,(-)]-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
中文名:
中文别名:
CBNumber:
CB72392032
分子式:
C18H22O6
分子量:
334.36
MOL File:
40785-65-7.mol

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione化学性质

沸点:
649.9±55.0 °C(Predicted)
密度:
1.241±0.06 g/cm3(Predicted)
酸度系数(pKa):
7.56±0.60(Predicted)
安全信息

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione性质、用途与生产工艺

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione 上下游产品信息

上游原料

下游产品

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione 生产厂家

全球有 0家供应商   (3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione国内生产厂家
 

40785-65-7, (3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione 相关搜索:

  • 40785-65-7
  • 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-5,14,16-trihydroxy-3-methyl-, (3S,5S,11E)-
  • F-5-4
  • 8'-epi-Hydroxyzearalenone
  • [3S,5S,11E,(-)]-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
  • (3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
  • (-)-8'-epi-Hydroxyzearalenone
Copyright 2016 © ChemicalBook. All rights reserved